InTrack Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-3,778
Closed -$322K – 101
2024
Q4
$322K Sell
3,778
-3,097
-45% -$268K 0.22% 91
2024
Q3
$619K Sell
6,875
-123
-2% -$10.3K 0.44% 65
2024
Q2
$551K Buy
6,998
+1,025
+17% +$84K 0.39% 75
2024
Q1
$521K Buy
5,973
+625
+12% +$53.3K 0.39% 79
2023
Q4
$441K Sell
5,348
-1,078
-17% -$82.2K 0.33% 94
2023
Q3
$504K Buy
6,426
+1,370
+27% +$115K 0.44% 77
2023
Q2
$445K Buy
5,056
+1,510
+43% +$130K 0.36% 92
2023
Q1
$282K Hold
3,546
– – 0.26% 105
2022
Q4
$276K Sell
3,546
-765
-18% -$62K 0.28% 98
2022
Q3
$348K Buy
4,311
+860
+25% +$77.3K 0.38% 81
2022
Q2
$310K Buy
3,451
+337
+11% +$34.1K 0.32% 90
2022
Q1
$346K Buy
+3,114
New +$329K 0.28% 95

Other funds holding MDT

InTrack Investment Management's MDT Position: Q1 2025 in Review

InTrack Investment Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 3,778 shares — an estimated $322K sold.

InTrack Investment Management first reported a position in MDT in Q1 2022 and held it in 12 quarters. The position peaked at $619K in Q3 2024. 2,177 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • InTrack Investment Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • InTrack Investment Management sold 3,778 Medtronic shares in Q1 2025, an estimated $322K.
  • InTrack Investment Management first reported a position in Medtronic in Q1 2022 and held it in 12 quarters.
  • InTrack Investment Management's Medtronic position peaked at $619K in Q3 2024.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on InTrack Investment Management's 13F filing for Q1 2025, filed 15 Apr 2025.